Department of Nephrology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Center for Nephrology and Clinical Metabolomics, Tongji University School of Medicine, Shanghai, China.
FASEB J. 2019 Dec;33(12):14370-14381. doi: 10.1096/fj.201901712R. Epub 2019 Oct 29.
Autophagy has been demonstrated to be vital for kidney homeostasis and is centrally implicated in the pathogenesis of cisplatin-induced acute kidney injury (AKI). Lithium is a potent autophagy inducer in a number of cell types. However, it remains uncertain whether its autophagic activity is associated with a beneficial effect on renal tubular cells in AKI. This study aimed to examine the effect of lithium on renal autophagy in cisplatin-induced AKI. Mice or renal proximal tubular epithelial cells in culture were exposed to cisplatin-induced acute injury in the presence or absence of lithium treatment. AKI or tubular cell injury was evaluated, and cell signaling associated with autophagy was examined. Lithium pretreatment prominently ameliorated acute renal tubular damage in mice exposed to cisplatin insult, associated with enhanced autophagy in renal tubules, as assessed by measuring microtubule-associated protein 1A/1B-light chain 3 (LC3)BII/I expression and autophagosome formation. Consistently, in cisplatin-injured renal tubular cells , lithium enhanced autophagic activities, improved cell viability, and attenuated cell death. Mechanistically, lithium triggered AMPK-α phosphorylation and activation, which in turn positively correlated with the induced expression of autophagy-related molecules, like mammalian target of rapamycin and LC3BII/I. AMPK-α activation is likely required for lithium-induced tubular cell autophagy and protection in cisplatin-induced AKI because blockade of AMPK-α phosphorylation by compound C markedly abrogated lithium-induced autophagosome formation and mitigated the protective effect of lithium on AKI. Our findings suggest that lithium represents a promising therapeutic strategy for protecting renal tubular cells against cisplatin-induced AKI by enhancing autophagy AMPK-α activation.-Bao, H., Zhang, Q., Liu, X., Song, Y., Li, X., Wang, Z., Li, C., Peng, A., Gong, R. Lithium targeting of AMPK protects against cisplatin-induced acute kidney injury by enhancing autophagy in renal proximal tubular epithelial cells.
自噬对于肾脏内稳态至关重要,并且在顺铂诱导的急性肾损伤(AKI)的发病机制中起着核心作用。在许多细胞类型中,锂是一种有效的自噬诱导剂。然而,其自噬活性是否与 AKI 中肾小管细胞的有益作用相关仍然不确定。本研究旨在探讨锂对顺铂诱导的 AKI 中肾脏自噬的影响。在存在或不存在锂处理的情况下,将小鼠或肾近端肾小管上皮细胞暴露于顺铂诱导的急性损伤中。评估 AKI 或管状细胞损伤,并检查与自噬相关的细胞信号。锂预处理显著改善了暴露于顺铂损伤的小鼠的急性肾小管损伤,与肾小管中自噬增强相关,通过测量微管相关蛋白 1A/1B-轻链 3(LC3)BII/I 表达和自噬体形成来评估。一致地,在顺铂损伤的肾小管细胞中,锂增强了自噬活性,提高了细胞活力,并减轻了细胞死亡。在机制上,锂触发 AMPK-α磷酸化和激活,这与自噬相关分子(如雷帕霉素哺乳动物靶标和 LC3BII/I)的诱导表达呈正相关。AMPK-α的激活可能是锂诱导的管状细胞自噬和在顺铂诱导的 AKI 中保护所必需的,因为化合物 C 阻断 AMPK-α磷酸化会显著消除锂诱导的自噬体形成,并减轻锂对 AKI 的保护作用。我们的研究结果表明,锂通过增强自噬和 AMPK-α激活来代表一种有前途的治疗策略,用于保护肾小管细胞免受顺铂诱导的 AKI。